Long-term Outcomes and Toxicity in Patients with Metastatic Non Small Cell Lung Cancer Treated with Immunotherapy Containing Regimens

被引：0
|
作者：
Maddula, M. [1 ,2 ]
Brown, L. J. [1 ,2 ,3 ,4 ]
Gao, B. [1 ,2 ,3 ]
da Silva, I. Pires [1 ,2 ,3 ,5 ]
Nagrial, A. [1 ,2 ,3 ]
机构：
[1] Westmead Hosp, Crown Princess Mary Canc Ctr, Sydney, NSW, Australia
[2] Blacktown Hosp, Med Oncol, Sydney, NSW, Australia
[3] Univ Sydney, Camperdown, NSW, Australia
[4] Westmead Inst Med Res, Westmead, NSW, Australia
[5] Melanoma Inst Australia, Sydney, NSW, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Metastatic Non Small Cell Lung Cancer; Immunotherapy; Long-term outcomes;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.03-07
引用
收藏
页码：S622 / S622
页数：1
相关论文
共 50 条
  • [1] Long-term survival in three patients with metastatic non-small cell lung cancer treated with gefitinib
    Nakatomi, K
    Soda, H
    Kitazaki, T
    Nakano, H
    Uchida, K
    Urabe, S
    Nakamura, Y
    Hayashi, T
    Tsukamoto, K
    Kohno, S
    LUNG CANCER, 2006, 52 (02) : 253 - 255
  • [2] Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy
    Galli, Giulia
    Proto, Claudia
    Signorelli, Diego
    Imbimbo, Martina
    Ferrara, Roberto
    Prelaj, Arsela
    De Toma, Alessandro
    Ganzinelli, Monica
    Zilembo, Nicoletta
    de Braud, Filippo
    Garassino, Marina C.
    Lo Russo, Giuseppe
    FUTURE ONCOLOGY, 2019, 15 (23) : 2743 - 2757
  • [3] Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail
    Daylan, Ayse Ece Cali
    Halmos, Balazs
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (07) : 1636 - 1642
  • [4] Long-term outcomes with nivolumab in patients with previously treated advanced Non-Small Cell Lung Cancer (NSCLC)
    Thomas, M.
    Kohlhaeufl, M.
    Reck, M.
    Engel-Riedel, W.
    Kortsik, C.
    Bullinger, L.
    Schneider, C. -P.
    Felip, E.
    Brahmer, J.
    Vokes, E.
    Gettinger, S.
    Geese, W.
    Yoon, D.
    Healey, D.
    Li, A.
    Eberhardt, W. E. E.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 137 - 137
  • [5] Predictive Toxicity and Response to Immunotherapy in Patients with Metastatic Non Small Cell Lung Cancer (IMMUNOPREDICT)
    Nguyen, J.
    Quere, G.
    Descourt, R.
    Geier, M.
    Babey, H.
    Saliou, P.
    Picard, J.
    Dhamelincourt, E.
    Fave, T.
    Laune, Q.
    Simaki, A.
    Renaud, E.
    Cornec, D.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S618 - S618
  • [6] The effect of sex and BMI on outcomes in patients with metastatic non-small cell lung cancer treated with immunotherapy.
    Jin, Jingxiao
    Visina, Jacqueline
    Burns, Timothy F.
    Diergaarde, Brenda
    Stabile, Laura P.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Impact of Antibiotics on Outcome of Metastatic Non Small Cell Lung Cancer Patients Treated with Immunotherapy
    Galli, G.
    Poggi, M.
    Fuca, G.
    Imbimbo, M.
    Proto, C.
    Signorelli, D.
    Vitali, M.
    Zilembo, N.
    Ganzinelli, M.
    De Braud, F.
    Garassino, M.
    Lo Russo, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S389 - S389
  • [8] Characterization of patients with metastatic non-small cell lung cancer obtaining long term benefit from immunotherapy
    Galli, G.
    Proto, C.
    Signorelli, D.
    Imbimbo, M.
    Ferrara, R.
    Prelaj, A.
    De Toma, A.
    Randon, G.
    Trevisan, B.
    Ganzinelli, M.
    Zilembo, N.
    Garassino, M. C.
    Lo Russo, G.
    ANNALS OF ONCOLOGY, 2019, 30 : 56 - 56
  • [9] Investigation of opioid use and long-term oncologic outcomes for non-small cell lung cancer patients treated with surgery
    Oh, Tak Kyu
    Jeon, Jae Hyun
    Lee, Jong Mog
    Kim, Moon Soo
    Kim, Jee Hee
    Cho, Hyeyeon
    Kim, Seong-eun
    Eom, Woosik
    PLOS ONE, 2017, 12 (07):
  • [10] Long-term survival in patients with non-small cell lung cancer treated with palliative radiotherapy
    Quddus, AMMZ
    Kerr, GR
    Price, A
    Gregor, A
    CLINICAL ONCOLOGY, 2001, 13 (02) : 95 - 98
12345